I docetaxel - plus trastuzumab - armen, havde 64% modtaget en tidligere behandling med antracyclin som adjuverende behandling sammenlignet med 55% i docetaxel- armen alene.
In the docetaxel plus trastuzumab arm, 64% had received a prior anthracycline as adjuvant therapy compared with 55% in the docetaxel arm alone.